| Financial Year |
March 31 2023 |
| Monetary Funds |
2,307,457,066.45 |
| Held-for-trading Financial Assets |
34,709,003.67 |
| Notes Receivable |
164,277,878.90 |
| Accounts Receivable |
2,762,715,253.35 |
| Advances to Suppliers |
17,160,521.44 |
| Other Receivables |
29,825,382.58 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
3,329,077,606.92 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
158,066,239.24 |
| Total Current Assets |
8,968,585,240.86 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
369,896,325.51 |
| Investment Properties |
28,637,144.42 |
| Fixed Assetes |
1,431,632,341.23 |
| Under-construction Projects |
326,847,207.26 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
121,159,114.44 |
| R&D expenses |
-- |
| Goodwill |
26,615,164.81 |
| Long-Term Deferred and Prepaid Expenses |
65,667,986.73 |
| Deferred Income Tax Assets |
44,905,008.87 |
| Other Non-Current Assets |
174,102,611.77 |
| Sub-Total of Non-Current Assets |
2,643,144,477.67 |
| Total Assets |
11,611,729,718.53 |
| Short-Term Loans |
1,552,465,677.92 |
| Trading Financial liabilities |
4,893,010.75 |
| Notes Payable |
317,854,539.00 |
| Accounts Payable |
1,062,633,002.33 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
119,913,649.82 |
| Taxes Payable |
71,767,362.13 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
87,200,750.09 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
45,082,390.83 |
| Other Current Liabilities |
502,475.71 |
| Sub-Total of Current Liabilities |
3,354,458,947.42 |
| Long-term Loans |
386,350,691.97 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
11,377,704.40 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
506,981,842.86 |
| Total Liabilities |
3,861,440,790.28 |
| Paid-In Capital(Or Share Stock) |
1,215,725,773.00 |
| Capital Surplus |
982,315,458.00 |
| Surplus Reserve |
318,279,901.02 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
4,013,833,569.18 |
| Minority Stockholder's Interest |
1,207,971,029.89 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
6,542,317,898.36 |
| Owner's Equity（Stockholder's Equity） |
7,750,288,928.25 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
11,611,729,718.53 |
